These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35432097)

  • 1. Innovation to Immune: Empirical Evidence From COVID-19 Focused Enterprise Surveys.
    Khan K; Liu S; Xiong B; Zhang L; Li C
    Front Psychol; 2022; 13():850842. PubMed ID: 35432097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Window of Opportunity: Radical Versus Repurposing Innovation Under Conditions of Environmental Uncertainty and Crisis.
    Dunlap DR; Santos RS; Latham SF
    IEEE Trans Eng Manag; 2024; 71():6540-6552. PubMed ID: 38665304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholder network for developing open innovation practice of China's manufacturing enterprises.
    Lyu B; Yi R; Fan G; Zhang Y
    Heliyon; 2023 Mar; 9(3):e13192. PubMed ID: 37101472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Guidance' or 'Misleading'? The government subsidy and the choice of enterprise innovation strategy.
    Ding J; Wang J; Liu B; Peng L
    Front Psychol; 2022; 13():1005563. PubMed ID: 36267081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of psychological contract breach on firm's innovative performance: A moderated mediation model.
    Zhang L
    Front Psychol; 2022; 13():970622. PubMed ID: 36092046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition and firm recovery post-COVID-19.
    Bruhn M; Demirguc-Kunt A; Singer D
    Small Bus Econ (Dordr); 2023 May; ():1-32. PubMed ID: 38625181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dilemma of Service Productivity and Service Innovation: An Empirical Exploration in Financial Services.
    Aspara J; Klein JF; Luo X; Tikkanen H
    J Serv Res; 2018 May; 21(2):249-262. PubMed ID: 29706764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How R&D intensive firms react to the COVID-19 pandemic: Evidence from a quasi-natural experiment.
    Pham THL; Nguyen DHT; Chu VT; Nguyen KD; Pham BT
    Heliyon; 2023 Sep; 9(9):e19329. PubMed ID: 37662736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Do Green Innovation Strategies Contribute to Firm Performance Under Supply Chain Risk? Evidence From China's Manufacturing Sector.
    Wang M; Liu Z
    Front Psychol; 2022; 13():894766. PubMed ID: 35572315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of eco-city construction on firm innovation in the case of China.
    Song Z; Xuan Y; Ren S
    Environ Sci Pollut Res Int; 2021 Jul; 28(28):37547-37561. PubMed ID: 33715126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Firm's Unethical Behavior in Investment Decisions Among Young Investors in China.
    Tang X; Yu K; Yu W
    Psychol Res Behav Manag; 2022; 15():3427-3443. PubMed ID: 36466762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sadder but Wiser: The Role of SARS Imprinting and Firms' Recovery During the COVID-19 Pandemic.
    Yao H; Wang J; Bo Q; Li M
    Front Psychol; 2022; 13():917337. PubMed ID: 35756304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
    Aristei D; Gallo M
    Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Do Heterogeneous Networks Affect a Firm's Innovation Performance? A Research Analysis Based on Clustering and Classification.
    Zhang L; Qiu H; Chen J; Zhou W; Li H
    Entropy (Basel); 2023 Nov; 25(11):. PubMed ID: 37998252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative strategies and corporate profitability: the positive resources dependence from political network.
    Nguyen SK; Vo XV; Vo TMT
    Heliyon; 2020 Apr; 6(4):e03788. PubMed ID: 32373728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Relationship Between Value Modularity, Knowledge Transfer, and Firm Innovation Performance: Evidence From China.
    Wang J; Zhao Y; Han X; Li L; Rasool SF
    Front Psychol; 2021; 12():772231. PubMed ID: 35069351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discretionary Effort on Green Technology Innovation: How Chinese Enterprises Act when Facing Financing Constraints.
    Zhang K; Liu X; Hong M
    PLoS One; 2021; 16(12):e0261589. PubMed ID: 34936690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.